Pacira BioSciences (PCRX) Competitors $22.35 -0.71 (-3.08%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$22.14 -0.21 (-0.96%) As of 10/10/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX vs. PRGO, SUPN, NKTR, OMER, ASMB, CPIX, LLY, JNJ, ABBV, and MRKShould you be buying Pacira BioSciences stock or one of its competitors? The main competitors of Pacira BioSciences include Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), Cumberland Pharmaceuticals (CPIX), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co., Inc. (MRK). These companies are all part of the "pharmaceuticals" industry. Pacira BioSciences vs. Its Competitors Perrigo Supernus Pharmaceuticals Nektar Therapeutics Omeros Assembly Biosciences Cumberland Pharmaceuticals Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Perrigo (NYSE:PRGO) and Pacira BioSciences (NASDAQ:PCRX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk. Is PRGO or PCRX more profitable? Perrigo has a net margin of -1.86% compared to Pacira BioSciences' net margin of -18.08%. Pacira BioSciences' return on equity of 13.29% beat Perrigo's return on equity.Company Net Margins Return on Equity Return on Assets Perrigo-1.86% 9.09% 3.96% Pacira BioSciences -18.08%13.29%6.61% Does the media prefer PRGO or PCRX? In the previous week, Perrigo had 1 more articles in the media than Pacira BioSciences. MarketBeat recorded 8 mentions for Perrigo and 7 mentions for Pacira BioSciences. Pacira BioSciences' average media sentiment score of 1.18 beat Perrigo's score of 0.92 indicating that Pacira BioSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Perrigo 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pacira BioSciences 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, PRGO or PCRX? Pacira BioSciences has lower revenue, but higher earnings than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerrigo$4.37B0.67-$171.80M-$0.58-36.64Pacira BioSciences$700.97M1.43-$99.56M-$2.78-8.04 Do analysts rate PRGO or PCRX? Perrigo presently has a consensus target price of $34.00, suggesting a potential upside of 60.00%. Pacira BioSciences has a consensus target price of $33.40, suggesting a potential upside of 49.44%. Given Perrigo's higher possible upside, analysts plainly believe Perrigo is more favorable than Pacira BioSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perrigo 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20Pacira BioSciences 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has more risk & volatility, PRGO or PCRX? Perrigo has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, Pacira BioSciences has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Do institutionals & insiders have more ownership in PRGO or PCRX? 95.9% of Perrigo shares are owned by institutional investors. Comparatively, 99.7% of Pacira BioSciences shares are owned by institutional investors. 0.7% of Perrigo shares are owned by company insiders. Comparatively, 6.4% of Pacira BioSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryPacira BioSciences beats Perrigo on 10 of the 16 factors compared between the two stocks. Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PCRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCRX vs. The Competition Export to ExcelMetricPacira BioSciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$3.38B$6.11B$10.63BDividend YieldN/A2.29%5.66%4.71%P/E Ratio-8.0421.9785.2726.57Price / Sales1.43462.21612.79132.63Price / Cash5.3447.2238.5062.09Price / Book1.3310.2112.726.53Net Income-$99.56M-$52.40M$3.30B$275.96M7 Day Performance-10.02%0.88%0.95%-0.73%1 Month Performance-17.31%10.41%6.35%3.71%1 Year Performance37.79%27.28%80.42%37.30% Pacira BioSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCRXPacira BioSciences3.7329 of 5 stars$22.35-3.1%$33.40+49.4%+44.1%$1.04B$700.97M-8.04720Positive NewsAnalyst ForecastPRGOPerrigo4.9222 of 5 stars$22.07-2.0%$34.00+54.1%-12.4%$3.10B$4.37B-38.058,379News CoverageAnalyst ForecastSUPNSupernus Pharmaceuticals4.0137 of 5 stars$48.31-0.1%$51.50+6.6%+53.7%$2.71B$661.82M42.01580Trending NewsAnalyst ForecastInsider TradeNKTRNektar Therapeutics4.0182 of 5 stars$59.93-1.0%$91.67+53.0%+180.8%$1.15B$98.43M-6.81220Positive NewsAnalyst ForecastOMEROmeros3.6125 of 5 stars$4.61+0.7%$18.00+290.5%+10.0%$311.70MN/A-2.18210News CoveragePositive NewsAnalyst ForecastASMBAssembly Biosciences3.5943 of 5 stars$24.48+5.0%$41.25+68.5%+65.2%$178.92M$28.52M-4.39100News CoverageAnalyst ForecastCPIXCumberland Pharmaceuticals0.919 of 5 stars$3.09-1.3%N/A+165.4%$46.83M$37.87M-14.0580News CoverageAnalyst ForecastLLYEli Lilly and Company4.9914 of 5 stars$845.40+0.7%$938.94+11.1%-8.5%$794.90B$45.04B55.2547,000Trending NewsAnalyst ForecastJNJJohnson & Johnson4.6664 of 5 stars$188.23-0.2%$189.12+0.5%+18.8%$454.31B$88.82B20.13138,100Trending NewsUpcoming EarningsAnalyst ForecastABBVAbbVie4.5786 of 5 stars$230.28-1.6%$228.22-0.9%+18.8%$413.22B$56.33B109.6655,000Positive NewsAnalyst ForecastMRKMerck & Co., Inc.4.9928 of 5 stars$88.83-0.4%$106.41+19.8%-21.4%$222.78B$63.62B13.6975,000Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Perrigo Competitors Supernus Pharmaceuticals Competitors Nektar Therapeutics Competitors Omeros Competitors Assembly Biosciences Competitors Cumberland Pharmaceuticals Competitors Eli Lilly and Company Competitors Johnson & Johnson Competitors AbbVie Competitors Merck & Co., Inc. Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PCRX) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
